ORIDIS Biomed provides research services and solutions for the analysis of human tissue, delivering medical validation to drug and biomarker development programs (“clinical trial on a chip”).

ORIDIS Biomed commercializes its proprietary TISSOMICS™ research platform in collaborations with partners in the pharmaceutical and biotechnology industry. The Company also uses its TISSOMICS™ platform in its own biomarker discovery and development programs.

ORIDIS Biomed’s unique offering combines rich and proven experience in the analysis of clinically relevant tissue with access to a biobank with 2.9 million samples of diseased human tissue and associated data.